Support our sponsors:

NZX 50 Index	3326.74	2.10
S&P/ASX 200	4282.90	7.80
Dow Jones Industrials	12884.00	5.80

Twitter

Facebook

RSS

Daily ShareChat: Fisher & Paykel Healthcare

By Jenny Ruth

Sunday 1st August 2010

Text too small?

The introduction of competitive bidding, including for the obstructive sleep apnea (OSA) products Fisher & Paykel Healthcare Corporation manufactures, in nine or 10 major US cities is unlikely to have a major impact on OSA producers, says Morningstar analyst Nachi Moghe.

The move by The Centre for Medicare and Medicaid (CMS) has resulted in significant reductions in reimbursement rates for OSA treatment, Moghe says.

Fisher & Paykel "says reimbursements were down 30% on average. This looks pretty significant at face value, especially when you compare it with (annual) price declines of around 5% seen so far," he says.

However, the vast majority of the cut in reimbursements relates to margins charged by home care dealers for providing sales and support services. "In other words, it is the home care dealers, and not producers, who are likely to bear the brunt."

CMS accounts for about 25% of Fisher & Paykel's US OSA sales with private insurers making up the rest and private insurers already have competitive bidding in place, Moghe says.

He estimates CMS prices will drop 10% as competitive bidding is progressively introduced across all US states over a number of years and prices through private insurers will drop 3%. Given Fisher & Paykel's business split, this will work out at 5% overall, consistent with historic levels.

The company says it will counter this through launching new products.

Recommendation: Buy (upgraded from accumulate).

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Printable version

Get quotes for Fisher & Paykel Healthcare Corporation L (FPH)

NZX Annoucements for FPH

9 Feb 2012	RELINT: FPH: Disclosure of Directors Relevant Interests
9 Feb 2012	GENERAL: FPH: CAREFUSION & FPH RENEW EXCLUSIVE DISTRIBUTION AGREEMENT
31 Jan 2012	SSH: FPH: SSH Mondrian Investment Partners Limited
11 Jan 2012	ALLOT: FPH: NOTIFICATION OF ISSUE OF SECURITIES